FDA Approved: CLADRIBINE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s original ANDA for cladribine, a generic version of the cancer drug, intended for hairy cell leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hairy Cell Leukemia

Drugs mentioned

• Cladribine (cladribine)

Snippet

ORIG AP for CLADRIBINE (CLADRIBINE)